Stay updated on SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Results from the study have been posted on the page, and the study record dates show updates including 'Results First Posted' on 2025-05-30 and the latest update on 2025-06-25.
    Difference
    0.4%
    Check dated 2025-11-03T21:13:43.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:49:22.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a new version without other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:10:16.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1) and the Back to Top link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:20:09.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T16:07:41.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a new facility name and location details, while also removing several key medical terms and references related to breast cancer treatments.
    Difference
    2%
    Check dated 2025-08-31T11:57:59.000Z thumbnail image

Stay in the know with updates to SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.